Commit Biologics

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

EpiBiologics

This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

Bluefin Biomedicine

This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Beeline Medicines

This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.